Similar articles

• Re: Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

  Warren JL, Brown ML. Warren JL, et al. J Natl Cancer Inst. 2007 Jul 4;99(13):1050; author reply 1051-2. doi: 10.1093/jnci/djm015. Epub 2007 Jun 27. J Natl Cancer Inst. 2007. PMID: 17596580 No abstract available.
• Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.

  Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. Hershman D, et al. J Natl Cancer Inst. 2007 Feb 7;99(3):196-205. doi: 10.1093/jnci/djk028. J Natl Cancer Inst. 2007. PMID: 17284714
• Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk.

  Patt DA, Duan Z, Fang S, Hortobagyi GN, Giordano SH. Patt DA, et al. J Clin Oncol. 2007 Sep 1;25(25):3871-6. doi: 10.1200/JCO.2007.12.0832. Epub 2007 Jul 30. J Clin Oncol. 2007. PMID: 17664457
• Granulocyte colony-stimulating factor: key (f)actor or innocent bystander in the development of secondary myeloid malignancy?

  Touw IP, Bontenbal M. Touw IP, et al. J Natl Cancer Inst. 2007 Feb 7;99(3):183-6. doi: 10.1093/jnci/djk057. J Natl Cancer Inst. 2007. PMID: 17284707 Review. No abstract available.
• Granulocyte colony-stimulating factors and risk of acute myeloid leukemia and myelodysplastic syndrome.

  Lyman GH, Kuderer NM. Lyman GH, et al. Cancer Treat Res. 2011;157:167-78. doi: 10.1007/978-1-4419-7073-2_10. Cancer Treat Res. 2011. PMID: 21052956 Review. No abstract available.